Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $91.84 which represents a slight increase of $0.19 or 0.21% from the prior close of $91.65. The stock opened at $92.01 and ...

Gilead Sciences’ Livdelzi (seladelpar) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with the rare liver disease primary biliary cholangitis (PBC) ...

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’ Substack by Magnus Ofstad. In this ...

The drug has given promising results for the treatment of multiple myeloma, a rare form of blood cancer. The market for such ...

Ash Shehata from KPMG discusses how investors are feeling about the pharma and life sciences industry heading into 2025.

So, every year, thousands of Indian techies move to the US with H-1B visas. In FY 2023, the Office of Homeland Security ...